✦ LIBER ✦

A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis

✍ Scribed by Kimura, Hiroshi; Kanahara, Nobuhisa; Komatsu, Naoya; Ishige, Minoru; Muneoka, Katsumasa; Yoshimura, Masayuki; Yamanaka, Hiroshi; Suzuki, Tomotaka; Komatsu, Hideki; Sasaki, Tsuyoshi; Hashimoto, Tasuku; Hasegawa, Tadashi; Shiina, Akihiro; Ishikawa, Masatomo; Sekine, Yoshimoto; Shiraishi, Tetsuya; Watanabe, Hiroyuki; Shimizu, Eiji; Hashimoto, Kenji; Iyo, Masaomi

Book ID: 122254497
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 498 KB
Volume: 155
Category: Article
ISSN: 0920-9964
DOI: 10.1016/j.schres.2014.02.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2742 – A prospective comparative study o

2742 – A prospective comparative study of risperidone long-acting injection for treatment-resistant schizophrenia with dopamine supersensitivity psychosis

✍ Kimura, H.; Kanahara, N.; Komatsu, N.; Ishige, M.; Muneoka, K.; Yoshimura, M.; Y 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 33 KB

Potential treatment strategy of risperid

Potential treatment strategy of risperidone in long-acting injectable form for schizophrenia with dopamine supersensitivity psychosis

✍ Kimura, Hiroshi; Kanahara, Nobuhisa; Watanabe, Hiroyuki; Iyo, Masaomi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 114 KB

P.3.b.013 Risperidone in long-acting inj

P.3.b.013 Risperidone in long-acting injectable form and treatment-resistant schizophrenia with dopamine supersensitivity psychosis

✍ Kimura, H.; Kanahara, N.; Komatsu, N.; Muneoka, K.; Yamanaka, H.; Suzuki, T.; Ko 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 68 KB

P.3.c.058 Interim-analysis of a long-ter

P.3.c.058 Interim-analysis of a long-term treatment study with long-acting injectable risperidone and oral second generation antipsychotics in schizophrenia

✍ B. Ibach; A. Schreiner 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Does long-acting injectable risperidone

Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS)

✍ Lamiae Grimaldi-Bensouda; Frederic Rouillon; Bernard Astruc; Michel Rossignol; J 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 291 KB

TREATMENT COMPLETION RATES OF OLANZAPINE

TREATMENT COMPLETION RATES OF OLANZAPINE AND RISPERIDONE IN LONG ACTING INJECTABLE FORMULATIONS FOR THE TREATMENT OF SCHIZOPHRENIA: A COMPARISON OF SINGLE ARM OPEN-LABEL STUDIES

✍ Haya Ascher-Svanum; William Montgmery; Allen Brnabic; Anthony Lawson; Oladapo To 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB